| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $15.7M | -7.2% |
| SG&A Expense | $8.9M | -10.7% |
| Operating Income | -$24.7M | +8.5% |
| Net Income | -$23.5M | +8.4% |
| EPS (Basic) | -$0.43 | +14.0% |
| EPS (Diluted) | -$0.43 | +14.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.4M | -11.1% |
| Current Assets | $20.4M | -11.4% |
| Total Assets | $41.6M | -9.2% |
| Current Liabilities | $6.0M | +4.6% |
| Total Liabilities | $24.0M | -4.3% |
| Stockholders' Equity | $17.6M | -15.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.8M | +12.3% |
| Capital Expenditures | $556K | -37.3% |
| Investing Cash Flow | -$556K | +37.3% |
| Financing Cash Flow | $19.1M | — |
| Free Cash Flow | -$21.3M | +13.2% |